Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-05-10 @ 8:56 AM
Study NCT ID:
NCT02137356
Status:
UNKNOWN
Last Update Posted:
2015-09-03
First Post:
2014-05-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Sponsor:
Sheba Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
SHEBA-14-1061-YL-CTIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |